CClinicalTrials.gg
CompletedNCT07286799Updated Dec 31, 2025

Comparison of the Analgesic Efficacy of Transversalis Fascia Plane Block and Posterior Quadratus Lumborum Block in Pediatric Patient Undergoing Orchiopexy: A Prospective Observational Study

An observational study in Pain Management, Orchiopexy and Transversalis Fascia Plane Block, sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 1 Year to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-31.

Sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
54
Ages
1 Year to 7 Years
Sex
Male
01

Study summary

It was planned to compare the analgesic efficacy of the transversalis fascia plane block and the posterior quadratus lumborum block in children aged 1 to 7 years undergoing orchiopexy, by evaluating their FLACC scores and the time to first postoperative analgesic requirement.

02

Conditions studied

  • Pain Management
  • Orchiopexy
  • Transversalis Fascia Plane Block
  • Quadratus Lumborum Block

Browse trials for

Keywords

  • Transversalis fascia plane block
  • Quadratus lumborum block
  • Orchiopexy
  • Pain management
03

In context

Agnosia

1,190 studies on the registry are indexed under Agnosia; 508 are open to participants now.

This study's enrollment of 54 is below the median of 120 across 147 observational studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization is the lead sponsor of 84 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 7 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children aged 1 to 7 years with ASA physical status I-II undergoing unilateral orchiopexy surgery.

Inclusion criteria

  • Children aged 1 to 7 years with ASA physical status I-II undergoing unilateral orchiopexy surgery.

Exclusion criteria

Exclusion Criteria:

  • ASA physical status ≥ III
  • History of prematurity (gestational age \< 37 weeks) Known coagulation disorders or bleeding tendency
  • Infection, inflammation, or skin lesion at the injection site
  • Known neurological or neuromuscular diseases
  • Presence of significant cardiac or pulmonary disease (e.g., congenital heart disease, active asthma)
  • Hepatic or renal dysfunction
  • Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine, lidocaine)
  • Developmental delay or cognitive impairment that prevents accurate pain assessment
  • Use of additional regional analgesia techniques (e.g., caudal block) during surgery
  • Block failure or intraoperative complications requiring exclusion from protocol analysis
  • Lack of parental consent for participation in the study
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
54 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Children aged 1-7 years undergoing orchiopexy who received a transversalis fascia plane block.

    Children aged 1-7 years undergoing orchiopexy who received a transversalis fascia plane block.

  • Children Aged 1-7 Years Undergoing Orchiopexy Who Received a Posterior Quadratus Lumborum Block

    Children Aged 1-7 Years Undergoing Orchiopexy Who Received a Posterior Quadratus Lumborum Block

06

What researchers measure

Primary outcomes

  1. Time to First Analgesic Requirement After Surgery

    The time elapsed from the end of surgery to the administration of the first rescue analgesic.

    Time frame: First 24 hours postoperatively

Secondary outcomes

  1. FLACC Pain Scores at Specified Time Intervals

    Pain assessment using the Face, Legs, Activity, Cry, Consolability (FLACC) scale (score range: 0-10; higher scores indicate worse pain) at 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 12 hours, and 24 hours postoperatively.

    Time frame: First 24 hours postoperatively

07

Study locations

1 site
  • Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
    Istanbul, Şişli 34384, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07286799
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Responsible party
Reyhan Kucuk Erturk (Resident Doctor, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization) — Principal investigator
First posted
Dec 16, 2025
Start date
May 1, 2025
Primary completion
Nov 1, 2025
Completion
Nov 1, 2025
Last update
Dec 31, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion